Eli Lilly, Adaptimmune, Aurion Biotech, and ImmunityBio had breakthrough medicines and therapies debut in the past year.
1a). Darzalex (daratumumab), an anti-CD38 monoclonal antibody (mAb) for multiple myeloma, continues to be the biggest single growth driver for the company. AbbVie held on to the number two spot ...
Ignota Labs is using AI to fix failed drugs and bring them to market. It raised $6.9 million from investors with this pitch ...
A law passed in 2011 required food companies to track food in the event of contamination and a recall. The administration ...
NewsNation on MSN4h
Could Trump’s tariffs cause drug shortages, price increases?How could Trump’s tariffs affect prices, availability at the pharmacy? “That additional 10 percent tariff is going to have a fairly significant impact on the cost of goods for ...
Pharmaceutical giants are squaring off against telehealth companies and pharmacies selling custom-made versions of the hot ...
Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...
After years of weight loss drug shortages, the FDA is saying there's now an adequate supply for most medications and they ...
SaveHealth reports on the third-party companies that work to negotiate discounts with pharmacies and pharmacy benefit ...
Heart disease patients now have another treatment option. The U.S. Food and Drug Administration has approved Alnylam ...
The FDA wants to end bulk production of copycat versions of weight loss drugs; telehealth companies and compounding ...
Rogaine was approved by the Food and Drug Administration in 1988, the first drug to win the agency’s endorsement for male ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback